Description

S-2-(2-Benzo[1,3]Dioxol-5-Yl-Ethyl)-1,2,3,4-Tetrahydro-Quinoline is a sophisticated chiral organic compound featuring a tetrahydroquinoline core linked to a benzodioxole moiety. This unique molecular architecture makes it a valuable advanced pharmaceutical intermediate and a versatile building block for complex organic synthesis. It is primarily utilized by research and development organizations in the pharmaceutical and agrochemical sectors for the creation of novel active ingredients. The compound's specific stereochemistry and functional groups are critical for developing targeted molecules with enhanced biological activity.

Application

• Pharmaceutical Intermediate: Serves as a key chiral precursor in the synthesis of potential drug candidates, particularly for central nervous system (CNS) and other therapeutic areas.
• Agrochemical Research: Used as a building block in the development of new pesticides and herbicides, leveraging its complex heterocyclic structure.
• Asymmetric Synthesis: Employed as a chiral auxiliary or starting material in stereoselective chemical reactions to produce enantiomerically pure compounds.
• Medicinal Chemistry R&D: A crucial scaffold for structure-activity relationship (SAR) studies and the design of novel bioactive molecules in academic and industrial labs.
• Fine Chemical Production: Used in the multi-step synthesis of specialty chemicals requiring high purity and specific stereochemistry.

Basic Information

Item	Details
Product Name	S-2-(2-Benzo[1,3]Dioxol-5-Yl-Ethyl)-1,2,3,4-Tetrahydro-Quinoline
CAS No.	608525-33-3
Molecular Formula	C18H19NO2
Molecular Weight	281.35 g/mol
Synonyms	(S)-2-(2-(Benzo[d][1,3]dioxol-5-yl)ethyl)-1,2,3,4-tetrahydroquinoline; (S)-2-[2-(1,3-Benzodioxol-5-yl)ethyl]-1,2,3,4-tetrahydroquinoline; S-Tetrahydroquinoline benzodioxole derivative; (S)-2-(1,3-Benzodioxol-5-ylethyl)-1,2,3,4-tetrahydroquinoline; 1,2,3,4-Tetrahydro-2-[2-(1,3-benzodioxol-5-yl)ethyl]quinoline, (2S)-; Chiral Tetrahydroquinoline-Benzodioxole Hybrid
EINECS	Contact for details

Quality Control

Our production of S-2-(2-Benzo[1,3]Dioxol-5-Yl-Ethyl)-1,2,3,4-Tetrahydro-Quinoline adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot is characterized using advanced analytical techniques including HPLC, chiral chromatography, NMR, and mass spectrometry to confirm identity, purity, and enantiomeric excess. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment. We support compliance with cGMP standards for pharmaceutical intermediate applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Enantiomeric Excess (Chiral HPLC)	≥ 99.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.